Ironwood Pharmaceuticals Inc.

IRWD | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.46

+$0.05 (+1.13%)

Sep 22, 2026, 12:11 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.13%

(1D)

Rating

Updated: Sep 8, 2026

70.5

Fundamentals Strong

Market Sentiment Bullish

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $733.35M

1D Range

4.40 4.56

52W Range

1.26 5.78

Valuation (TTM)

PE 5.73

PB -4.49

EV/EBITDA 2.73

Valuation (NTM)

Forward PE 3.12

Forward PEG 0.73

Price Target $6.68

Cash Flow

FCF Yield 26.3%

SBC Adj. FCF Yield 22.7%

SBC Impact -13.7%

Margins

Gross Margin 99.8%

Operating Margin 60.6%

FCF Margin 49.0%

Growth (CAGR)

Revenue 3Y | 5Y -3.0% | -1.2%

Dil EPS 3Y | 5Y 144.6% | -24.4%

FCF 3Y | 5Y -10.2% | -3.5%

Returns

ROA 45.5%

ROE -57.4%

ROIC 57.9%

Financial Health

Net Cash

$67.26M

Current Ratio 6.06

Interest Coverage 7.23

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its f...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 100

IPO Date Feb 2, 2010

Website www.ironwoodpharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 9, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+12.11%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞